Klotho Neurosciences Files 8-K
Ticker: GRMLW · Form: 8-K · Filed: Jun 30, 2025 · CIK: 1907223
Sentiment: neutral
Topics: disclosure, financials, corporate-actions
Related Tickers: KLTO
TL;DR
Klotho Neurosciences (KLTO) filed an 8-K on 6/30/25 - standard disclosure update.
AI Summary
Klotho Neurosciences, Inc. filed an 8-K on June 30, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as ANEW Medical, Inc. and Redwoods Acquisition Corp., is incorporated in Delaware and operates in the Biological Products sector. Its principal executive offices are located in Omaha, Nebraska.
Why It Matters
This filing provides an update on Klotho Neurosciences' regulatory and financial disclosures, which is important for investors to stay informed about the company's current status.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for disclosures and exhibits, not indicating any immediate material changes or risks.
Key Players & Entities
- Klotho Neurosciences, Inc. (company) — Registrant
- ANEW Medical, Inc. (company) — Former Company Name
- Redwoods Acquisition Corp. (company) — Former Company Name
- June 30, 2025 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing for Klotho Neurosciences, Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on June 30, 2025.
What were Klotho Neurosciences, Inc.'s former names?
Klotho Neurosciences, Inc. was formerly known as ANEW Medical, Inc. and Redwoods Acquisition Corp.
In which state is Klotho Neurosciences, Inc. incorporated?
Klotho Neurosciences, Inc. is incorporated in Delaware.
What is the business address of Klotho Neurosciences, Inc.?
The business address of Klotho Neurosciences, Inc. is 13576 Walnut Street, Suite A, Omaha, NE 68144.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 30, 2025 regarding Klotho Neurosciences, Inc. (GRMLW).